Skip to content

A Study for the Effect of Binding Globin Type on Cardiovascular Disease and the Protective Effect of Vitamin E in Diabetic Patients

A Randomized Placebo-Controlled, Double Blind, Trial for the Effects of Vitamin E and Haptoglobin Type on Cardiovascular Disease Markers in Patients With Diabetes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024614
Enrollment
Unknown
Registered
2019-07-19
Start date
2019-10-02
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Case group:Take vitamin E

Sponsors

The Second Hospital of Shijiazhuang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes for at least 5 years; 2. Age: Male>=50 and Female>=55 years, or either gender>=40 years with es(filling one of the following): 1). History of myocardial infarction >3 months prior to informed consent; 2). Evidence of coronary artery disease i.e. in >=2 major coronary arteries or the left main coronary artery with significant stenosis ( >=50% luminal narrowing during angiography); 3). Previous revascularization (PTCA or CABG>3 months prior to consent).

Exclusion criteria

Exclusion criteria: 1. MI or CVA in the last 3 months (temporary exclusion, recruitment may be postponed); 2. Any malignancy during the last 5 years (excluding non-melanoma skin cancer); 3. End stage renal disease; 4. Treatment with any antioxidant supplements (Vitamin E, Vitamin A, Vitamin C, glutathione, lipoic acid, Coenzyme Q, Selenium, beta carotene, multivitamin) in the last year or treatment with herbal supplements/ herbal Chinese medicines in the last 3 months, or unwilling to avoid these supplements; 5. Known allergy to vitamin E.

Design outcomes

Primary

MeasureTime frame
Endothelial function test;Oxidative stress;Inflammatory cytokines;Genotyping;

Countries

China

Contacts

Public ContactLiu Zanchao

The Second Hospital of Shijiazhuang

liuzanchao2007@163.com+86 0311-87881723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026